DK0429676T3 - - Google Patents

Info

Publication number
DK0429676T3
DK0429676T3 DK90909377.5T DK90909377T DK0429676T3 DK 0429676 T3 DK0429676 T3 DK 0429676T3 DK 90909377 T DK90909377 T DK 90909377T DK 0429676 T3 DK0429676 T3 DK 0429676T3
Authority
DK
Denmark
Prior art keywords
those caused
cerebral
cerebral ischemia
brain functions
brain
Prior art date
Application number
DK90909377.5T
Other languages
English (en)
Inventor
Y Daiichi Shirasaki
Shinichiro Daiichi Ashida
Original Assignee
Santen Pharmaceutical Co Ltd
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd, Daiichi Seiyaku Co filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0429676T3 publication Critical patent/DK0429676T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK90909377.5T 1989-06-16 1990-06-14 DK0429676T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15364689 1989-06-16

Publications (1)

Publication Number Publication Date
DK0429676T3 true DK0429676T3 (da) 1997-03-10

Family

ID=15567085

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90909377.5T DK0429676T3 (da) 1989-06-16 1990-06-14

Country Status (8)

Country Link
US (1) US5182276A (da)
EP (1) EP0429676B1 (da)
KR (1) KR0133553B1 (da)
AT (1) ATE142881T1 (da)
CA (1) CA2032487A1 (da)
DE (1) DE69028603T2 (da)
DK (1) DK0429676T3 (da)
WO (1) WO1990015607A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015607A1 (fr) * 1989-06-16 1990-12-27 Santen Pharmaceutical Co., Ltd. Medicament pour l'ameliorations des fonctions cerebrales
EA019020B1 (ru) * 2011-07-12 2013-12-30 Институт Химических Проблем Им. М.Ф. Нагиева Национальной Академии Наук Азербайджана Способ лечения нарушений гемостаза при ушибах головного мозга
WO2024012554A1 (zh) * 2022-07-14 2024-01-18 上海日馨医药科技股份有限公司 Tpk激动剂及使用其治疗神经退行性疾病的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3166554A (en) * 1965-01-19 Certificate of correction
US3715353A (en) * 1970-10-12 1973-02-06 Squibb & Sons Inc (aminoalkoxy-benzylidene)-2h-benzothiazine-3(4h)-ones and related compounds
US3725403A (en) * 1970-10-20 1973-04-03 Squibb & Sons Inc Benzothiazine derivatives
JPS5651465A (en) * 1979-10-02 1981-05-09 Yoshitomi Pharmaceut Ind Ltd Benzothiazine derivative
JPS59148771A (ja) * 1983-02-09 1984-08-25 Santen Pharmaceut Co Ltd ベンゾチアジン誘導体
DE3347173A1 (de) * 1983-12-27 1985-07-04 Hoechst Ag, 6230 Frankfurt Neue benzothiazin-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
JPS60166674A (ja) * 1984-02-09 1985-08-29 Santen Pharmaceut Co Ltd ベンゾチアジン誘導体
EP0186310A1 (en) * 1984-11-28 1986-07-02 Takeda Chemical Industries, Ltd. 1,4-Benzothiazine Derivatives, their production and use
JPH0625186B2 (ja) * 1985-03-19 1994-04-06 参天製薬株式会社 ２−アリ−ルベンゾチアジン誘導体
US4786635A (en) * 1985-07-29 1988-11-22 Santen Pharmaceutical Co., Ltd. Novel benzothiazine derivatives
US4654372A (en) * 1986-01-10 1987-03-31 Warner-Lambert Company Method for using verapamil for treating stroke
DE3614363A1 (de) * 1986-04-28 1987-10-29 Hoechst Ag Benzothiazinon-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
DE3614355A1 (de) * 1986-04-28 1987-10-29 Hoechst Ag Neue benzothiazinon-derivate, verfahren zu ihrer herstellung , sie enthaltende arzneimittel und deren verwendung
JPH068284B2 (ja) * 1986-08-27 1994-02-02 参天製薬株式会社 ３−チオキソ−ベンゾチアジン誘導体
JPS6357578A (ja) * 1986-08-27 1988-03-12 Santen Pharmaceut Co Ltd ベンゾチアジン誘導体
JPS63104969A (ja) * 1986-10-23 1988-05-10 Santen Pharmaceut Co Ltd 含硫黄複素環化合物
WO1990015607A1 (fr) * 1989-06-16 1990-12-27 Santen Pharmaceutical Co., Ltd. Medicament pour l'ameliorations des fonctions cerebrales

Also Published As

Publication number Publication date
DE69028603D1 (de) 1996-10-24
KR0133553B1 (ko) 1998-04-23
WO1990015607A1 (fr) 1990-12-27
EP0429676A4 (en) 1992-05-20
CA2032487A1 (en) 1990-12-17
ATE142881T1 (de) 1996-10-15
KR920700645A (ko) 1992-08-10
DE69028603T2 (de) 1997-02-13
EP0429676A1 (en) 1991-06-05
US5182276A (en) 1993-01-26
EP0429676B1 (en) 1996-09-18

Similar Documents

Publication Publication Date Title
PL359340A1 (en) Triazole derivatives
NO900853L (no) Slitebane for kjoeretoeydekk med midtre partier forsynt medskraa innsnitt.
GR3019450T3 (en) Azaheterocyclylmethyl-chromans as agents for the treatment of diseases of the central nervous system
ATE227343T1 (de) Protease und verwandte dns-verbindungen
ATE222763T1 (de) Verwendung von imidazo-(1,2-a)-pyridin-3-acetamid-derivaten für die therapeutische behandlung von neuropsychiatrischen syndromen in zusammenhang mit störungen der nervenbahnen der basalganglien
AU624471B2 (en) Substituted quinolinecarboxylic acids
DK0429676T3 (da)
ES2080736T3 (es) Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas en el tratamiento de trastornos neurologicos.
RU94046220A (ru) N/гетеро/-арил-n/гетеро/-тетралин-алкилпиперазин, обладающий серотонинергической, допаминергической и адренергической активностью, способ их получения, терапевтическая композиция, применение
EP0303391A3 (en) Optical isomers of a spiroquinuclidine derivative
GR3015685T3 (en) 5-Aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders.
AU574208B2 (en) Temperature homogenisation of slabs
DE69836830D1 (de) Verwendung von proteinen der midkine-familie in der behandlung von ischämischen krankheiten
HU9201247D0 (en) Process for the production of condensed diazepinone derivatives and of mnedical preparations containing them as active agents
HUT56559A (en) Process for producing ascorbinic acid derivatives and pharma
FI93448C (fi) Menetelmä terapeuttisesti käyttökelpoisen triatsolo/4,5-c/pyridiinijohdannaisten valmistamiseksi
ES2096035T3 (es) Compuestos y procedimientos para el tratamiento de trastornos tromboembolicos.
ATE133865T1 (de) Therapeutisches mittel für erkrankungen des zentralnervensystems